Stay updated on ISB 830 Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedThe page now includes an expanded Locations section listing trial sites across the United States, Canada, and several European regions, and the revision tag was updated to v3.3.3.SummaryDifference2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe header now displays Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedOne site-wide notice about government funding and potential delays has been removed from the page. The removed notice warned that information might not be up to date and that NIH operations could be affected.SummaryDifference0.2%

- Check63 days agoChange DetectedNo additions or deletions are visible between the old and new screenshots; the page content and layout appear unchanged.SummaryDifference0.2%

- Check84 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference2%

- Check91 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply changes to core content or functionalities.SummaryDifference0.0%

Stay in the know with updates to ISB 830 Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page.